4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-21-133785
SVP, Chief Business Officer sold 27,500 shares at $5.00 ($137,500)
- SVP, Chief Business Officer acquired 27,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-11-01 | Option exercise | +27,500 | $0.92 | $25,300 | 44,667 | D |
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-11-01 | Sale | −27,500 | $5.00 | $137,500 | 17,167 | D |
| Derivatives | |||||||
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-11-01 | Option exercise · Stock Option (right to Buy) | −25,245 | 0 | D | ||
| Korbel Gregory Alan SVP, Chief Business Officer | 2021-11-01 | Option exercise · Stock Option (right to Buy) | −2,255 | 29,835 | D | ||
| Open-market sales · 27,500 sh · avg $5.00 · $137,500 | |||||||
Loading xslF345X03/tm2131764-1_4seq1.xml…